Current burden of MASLD, MetALD, and hepatic fibrosis among US adults with prediabetes and diabetes, 2017–2023

類似資料

• Prevalence of steatotic liver disease (MASLD, MetALD, ALD) and clinically significant fibrosis in US adolescents
  著者:: Guang-Xia Shi, 等
  出版事項: (2024-10-01)
• The burden of steatotic liver disease before and during the COVID-19 pandemic: Correspondence to editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”
  著者:: Donghee Kim, 等
  出版事項: (2025-04-01)
• Erratum to ‘Current burden of MASLD, MetALD, and hepatic fibrosis among US adults with prediabetes and diabetes, 2017–2023’ [Clin Mol Hepatol 2025;31:e235-e238]
  著者:: Donghee Kim, 等
  出版事項: (2025-10-01)
• Comparing similarities and differences between NAFLD, MAFLD, and MASLD in the general U.S. population
  著者:: Haoxuan Zou, 等
  出版事項: (2024-07-01)
• Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE score
  著者:: Pimsiri Sripongpun, 等
  出版事項: (2024-10-01)